Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) has been postulated to participate in a number of diverse physiological and pathological processes ranging from the homeostasis of plasma lipoproteins, atherosclerosis, and fibrinolysis to neuronal regeneration and survival. It has not been possible to demonstrate in vivo the physiological significance of LRP for each of these complex processes by a conventional gene knockout approach because LRP is essential for embryonic development. Here we have used the Cre/loxP recombination system to achieve inducible, tissue-specific and quantitative disruption of the LRP gene in adult mice. Inactivation of LRP in the livers of LDL receptor-deficient mice resulted in the accumulation of cholesterol-rich remnant lipoproteins in the circulation. In normal animals, this caused a compensatory upregulation of the LDL receptor in the liver. Conditional gene targeting has thus allowed us to isolate a specific physiological function of LRP for in vivo analysis and has provided unequivocal evidence for another LDL receptor-independent cholesterol clearance pathway in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Self-citationHerz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., & Stanley, K. K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03306.x · Cited by 959
Self-citation
Cited by
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
“Clearance of Alzheimer’s amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.”
BackgroundSelf-citationGinsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
“putative roles for LDL receptor-related protein 1 and heparan sulphate proteoglycans (particularly syndecan 1).(69,70) For chylomicron”
BackgroundSjögren, K., Liu, J.-L., Blad, K., Skrtic, S., Vidal, O., Wallenius, V., LeRoith, D., Törnell, J., Isaksson, O. G. P., Jansson, J.-O., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7088 · Cited by 938
Conditional control of gene expression in the mouse
Lewandoski, M. (2001) · Nature Reviews Genetics · doi:10.1038/35093537 · Cited by 781
Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., & Strickland, D. K. (2008) · Physiological Reviews · doi:10.1152/physrev.00033.2007 · Cited by 669
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Lipid droplets and liver disease: from basic biology to clinical implications
Gluchowski, N. L., Becuwe, M., Walther, T. C., & Farese, R. V. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.32 · Cited by 677
Liang, G., Yang, J., Horton, J. D., Hammer, R. E., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111421200 · Cited by 669
Self-citationMetabolic-associated fatty liver disease and lipoprotein metabolism
Heeren, J., & Scheja, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101238 · Cited by 646
“For efficient internalization, both LDLR and LRP1 depend on APOE as co-ligand.”
BackgroundLRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis
Boucher, P., Gotthardt, M., Li, W.-P., Anderson, R. G. W., & Herz, J. (2003) · Science · doi:10.1126/science.1082095 · Cited by 581
Self-citationEndothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier
Storck, S. E., Meister, S., Nahrath, J., Meißner, J. N., Schubert, N., Di Spiezio, A., Baches, S., Vandenbroucke, R. E., Bouter, Y., Prikulis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81108 · Cited by 477
“Functional characterization of the brain-to-blood efflux clearance of human amyloid-β peptide (1-40) across the rat blood-brain barrier.”
InfluentialLipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457
Self-citationFate tracing of mature hepatocytes in mouse liver homeostasis and regeneration
Malato, Y., Naqvi, S., Schürmann, N., Ng, R., Wang, B., Zape, J., Kay, M. A., Grimm, D., & Willenbring, H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59261 · Cited by 434
Raabe, M., Véniant, M. M., Sullivan, M. A., Zlot, C. H., Björkegren, J., Nielsen, L. B., Wong, J. S., Hamilton, R. L., & Young, S. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6576 · Cited by 395
“Mttpflox/flox mice were bred with “deleter” Cre transgenic mice (30), in which Cre is expressed in the germ cells, and Mx1-Cre transgenic mice (28, 31).”
Fujino, T., Asaba, H., Kang, M.-J., Ikeda, Y., Sone, H., Takada, S., Kim, D.-H., Ioka, R. X., Ono, M., Tomoyori, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0133792100 · Cited by 336
Wan, E., Yeap, X. Y., Dehn, S., Terry, R., Novak, M., Zhang, S., Iwata, S., Han, X., Homma, S., Drosatos, K., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301198 · Cited by 383
Akiyama, T. E., Sakai, S., Lambert, G., Nicol, C. J., Matsusue, K., Pimprale, S., Lee, Y.-H., Ricote, M., Glass, C. K., Brewer, H. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2607-2619.2002 · Cited by 368
“Nearly complete disruption of the PPAR gene was also demonstrated in the liver (not shown), a finding consistent with the results of earlier studies with the MX-Cre transgene in which a nearly complete pIpC deletion was shown in the liver (a tissue in which PPAR is not well expressed) and macrophages (44, 68, 72).”
ResultLiu, Q., Zerbinatti, C. V., Zhang, J., Hoe, H.-S., Wang, B., Cole, S. L., Herz, J., Muglia, L., & Bu, G. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.008 · Cited by 364
Self-citationPostprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Matsuda, M., Korn, B. S., Hammer, R. E., Moon, Y.-A., Komuro, R., Horton, J. D., Goldstein, J. L., Brown, M. S., & Shimomura, I. (2001) · Genes & Development · doi:10.1101/gad.891301 · Cited by 303
“Cre expression was induced by intraperitoneal injection of the interferon-inducer , polyinosinic-polycytidylic acid (pIpC) (Kuhn et al. 1995; Rohlmann et al, 1998).”
MethodSelf-citationDiverse roles for the LDL receptor family
Strickland, D. K., Gonias, S. L., & Argraves, W. S. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00526-4 · Cited by 284
Worthmann, A., John, C., Rühlemann, M. C., Baguhl, M., Heinsen, F.-A., Schaltenberg, N., Heine, M., Schlein, C., Evangelakos, I., Mineo, C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4357 · Cited by 318
Yang, Z., Strickland, D. K., & Bornstein, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008925200 · Cited by 297
Ma, Q., Zhao, Z., Sagare, A. P., Wu, Y., Wang, M., Owens, N. C., Verghese, P. B., Herz, J., Holtzman, D. M., & Zlokovic, B. V. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0286-0 · Cited by 281
Self-citationApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Gordts, P. L. S. M., Nock, R., Son, N.-H., Ramms, B., Lew, I., Gonzales, J. C., Thacker, B. E., Basu, D., Lee, R. G., Mullick, A. E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86610 · Cited by 274
“In a second approach, [3H]retinol-radiolabeled ApoC-III–depleted and ApoCIII–bearing TRLs (Figure 9A and Supplemental Figure 6) were evaluated for their uptake by primary hepatocytes isolated from tory effect of ApoC-III on the clearance of TRLs through LDLR and LRP1, which act in a redundant manner with respect to TR…”
MethodLiu, Q., Trotter, J., Zhang, J., Peters, M. M., Cheng, H., Bao, J., Han, X., Weeber, E. J., & Bu, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4067-10.2010 · Cited by 268
“LRP1 forebrain knock-out mice were generated by breeding the LRP loxP mice (Rohlmann et al., 1998) with CaMKII-driven Cre recombinase mice (Tsien et al.”
Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition
Liu, C.-C., Hu, J., Zhao, N., Wang, J., Wang, N., Cirrito, J. R., Kanekiyo, T., Holtzman, D. M., & Bu, G. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3442-16.2017 · Cited by 267
“Astrocytespecific Lrp1-KO mice (aLrp1 / ) were generated by breeding the Lrp1 floxed mice (Rohlmann et al., 1998) with GFAP-driven Cre recombinase mice (obtained from NCI Mouse Repository) (Bajenaru et al.”
MethodLoukinova, E., Ranganathan, S., Kuznetsov, S., Gorlatova, N., Migliorini, M. M., Loukinov, D., Ulery, P. G., Mikhailenko, I., Lawrence, D. A., & Strickland, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200427200 · Cited by 260
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255
Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene
Yang, J., Goldstein, J. L., Hammer, R. E., Moon, Y.-A., Brown, M. S., & Horton, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201524598 · Cited by 217
Self-citationMay, P., Rohlmann, A., Bock, H. H., Zurhove, K., Marth, J. D., Schomburg, E. D., Noebels, J. L., Beffert, U., Sweatt, J. D., Weeber, E. J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8872-8883.2004 · Cited by 236
“, chylomicron remnants (40) and protease-protease inhibitor complexes (reviewed in reference 19).”
BackgroundSelf-citationHerz, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00234-3 · Cited by 235
Self-citationLipodystrophy in Human Immunodeficiency Virus-Infected Patients
Chen, D., Misra, A., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020794 · Cited by 229
The role of hepatic lipase in lipoprotein metabolism and atherosclerosis
Santamarina-Fojo, S., Haudenschild, C., & Amar, M. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00005 · Cited by 230
Cell-Surface Proteomic Profiling in the Fly Brain Uncovers Wiring Regulators
Li, J., Han, S., Li, H., Udeshi, N. D., Svinkina, T., Mani, D. R., Xu, C., Guajardo, R., Xie, Q., Li, T., et al. (2020) · Cell · doi:10.1016/j.cell.2019.12.029 · Cited by 204
Stanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., & Esko, J. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38251 · Cited by 226
“LRPs may aid in the metabolism of lipoproteins after dietary challenge or under conditions in which other receptors are occupied or rendered inoperative (61, 63).”
BackgroundResultInfluentialLRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
Kanekiyo, T., Liu, C.-C., Shinohara, M., Li, J., & Bu, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3987-12.2012 · Cited by 211
“…To examine the effect of LRP1 deletion in vascular smooth muscle cells on A clearance in vivo, we generated vascular smooth muscle cell-specific LRP1-KO mice (smLrp1 / ) by breeding the Lrp1 floxed mice (Rohlmann et al., 1998) with sm22 -driven Cre recombinase mice (Holtwick et al., 2002).”
MethodInfluentialLipoprotein receptor signalling in atherosclerosis
Mineo, C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz338 · Cited by 219
“cloned as a protein with multiple LDL receptor type A repeats, which mediates chylomicron remnant uptake.(72,73) It was also identified as a re-”
BackgroundHepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism
Strong, A., Ding, Q., Edmondson, A. C., Millar, J. S., Sachs, K. V., Li, X., Kumaravel, A., Wang, M. Y., Ai, D., Guo, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63563 · Cited by 222
“To date, several additional receptors have been reported to facilitate clearance of TG-rich lipoproteins, including heparan-sulfate proteoglycans (HSPGs) (29), LDLR-related protein-1 (LRP1) (30), and syndecan-1 (31).”
BackgroundVitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?
McCann, J. C., & Ames, B. N. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27930 · Cited by 221
“undergo modification to become chylomicron remnants (CMRs) (211), which are smaller in size than chylomicrons, but retain dissolved lipid-soluble vitamins (212), such as vitamin K1.”
BackgroundLipoprotein receptors: new roles for ancient proteins
Willnow, T. E., Nykjaer, A., & Herz, J. (1999) · Nature Cell Biology · doi:10.1038/14109 · Cited by 181
“In the liver, the central organ that takes up and redistributes lipids to other tissues in the body, LRP indeed works in concert with the LDL receptor and mediates the uptake of chylomicron remnants, the carriers of dietary lipids, into hepatocyte”
BackgroundSelf-citationPowell-Braxton, L., Véniant, M., Latvala, R. D., Hirano, K.-I., Won, W. B., Ross, J., Dybdal, N., Zlot, C. H., Young, S. G., & Davidson, N. O. (1998) · Nature Medicine · doi:10.1038/nm0898-934 · Cited by 192
Hasty, A. H., Shimano, H., Osuga, J.-I., Namatame, I., Takahashi, A., Yahagi, N., Perrey, S., Iizuka, Y., Tamura, Y., Amemiya-Kudo, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010176200 · Cited by 219
Ulery, P. G., Beers, J., Mikhailenko, I., Tanzi, R. E., Rebeck, G. W., Hyman, B. T., & Strickland, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7410 · Cited by 271
MacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A., Witztum, J. L., & Esko, J. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29154 · Cited by 216
Romagnuolo, R., Scipione, C. A., Boffa, M. B., Marcovina, S. M., Seidah, N. G., & Koschinsky, M. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611988 · Cited by 206
“However, plasma LDL is predominately cleared through the LDLR (37, 38).”
BackgroundEngelking, L. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25614 · Cited by 193
“Insig1+/f mice were bred to MX1-Cre transgenic mice to generate Insig1f/f MX1-Cre (L-Insig1–/–) mice (43).”
Ruiz, J., Kouiavskaia, D., Migliorini, M., Robinson, S., Saenko, E. L., Gorlatova, N., Li, D., Lawrence, D., Hyman, B. T., Weisgraber, K. H., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500114-jlr200 · Cited by 204
“In the liver, LRP plays an important role in chylomicron remnant metabolism (21), whereas in the vasculature, LRP plays an atheroprotective role by suppressing platelet-derived growth factor signaling pathways, thereby inhibiting vascular smooth muscle cell proliferation and migration (22).”
BackgroundInactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion
Wang, Y., Gusarova, V., Banfi, S., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m054882 · Cited by 189
“Liver-specific Lrp1 knockout (KO) mice were from Joachim Herz (UT Southwestern, Dallas, TX) (25).”
MethodThe regulation of ApoB metabolism by insulin
Haas, M. E., Attie, A. D., & Biddinger, S. B. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.04.001 · Cited by 187
The metabolism of triglyceride-rich lipoproteins revisited: New players, new insight
Dallinga-Thie, G. M., Franssen, R., Mooij, H. L., Visser, M. E., Hassing, H. C., Peelman, F., Kastelein, J. J. P., Péterfy, M., & Nieuwdorp, M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.027 · Cited by 181
“[68] The contribution of LRP1 in remnant clearance has been demonstrated by Rohlmann et al.[28,69] Defective remnant clearance could only be found if both the LDLr and LRP1 were silenced.”
BackgroundOf mice and models: improved animal models for biomedical research
Bockamp, E., Maringer, M., Spangenberg, C., Fees, S., Fraser, S., Eshkind, L., Oesch, F., & Zabel, B. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00067.2002 · Cited by 180
“However, the use of this Mx1-Cre deleter strain was essentially limited to excision of alleles in the liver and the immune system since recombination in other tissues was poor (76, 114).”
MethodHIV–Associated Lipodystrophy: Pathogenesis, Prognosis, Treatment, and Controversies
Koutkia, P., & Grinspoon, S. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104412 · Cited by 179
“Inhibition of LRP by PIs may not account for hyperlipidemia, since inactivation of LRP in the liver of wild-type mice does not result in hyperlipidemia (28).”
BackgroundHuszar, D., Varban, M. L., Rinninger, F., Feeley, R., Arai, T., Fairchild-Huntress, V., Donovan, M. J., & Tall, A. R. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.4.1068 · Cited by 173
Macrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation
Yancey, P. G., Blakemore, J., Ding, L., Fan, D., Overton, C. D., Zhang, Y., Linton, M. F., & Fazio, S. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202051 · Cited by 168
Hofmann, S. M., Zhou, L., Perez-Tilve, D., Greer, T., Grant, E., Wancata, L., Thomas, A., Pfluger, P. T., Basford, J. E., Gilham, D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31929 · Cited by 165
Self-citationThe low-density lipoprotein receptor gene family: multiple roles in lipid metabolism
Willnow, T. E. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050356 · Cited by 166
“Liver-specific knockout Mouse Hyperlipidemiaa [44]”
BackgroundMolecular processes that handle — and mishandle — dietary lipids
Williams, K. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35206 · Cited by 160
Conditional transgenic technologies
Ryding, A., Sharp, M., & Mullins, J. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1710001 · Cited by 160
“Kuhn et al. (1995) have used an interferon-inducible promoter to control Cre expression, and this has been used successfully to delete the low density lipoprotein receptor-related protein in hepatocytes (Rohlmann et al. 1998).”
MethodMahley, R. W., & Huang, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30889 · Cited by 159
Felmlee, D., Hafirassou, M., Lefevre, M., Baumert, T., & Schuster, C. (2013) · Viruses · doi:10.3390/v5051292 · Cited by 158
“…studies employing genetic knockout in hepatocytes of both LDLr and LRP1, there was a marked increase in TRL remnants, whereas inactivation of LRP1 alone did not significantly impact TRL remnant clearance, indicating that physiologically LRP1 plays a more minor role in lipoprotein uptake [136].”
BackgroundMore than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158
“The low-density lipoprotein receptor (LDLR) family is a highly conserved receptor family with diverse functions in cellular physiology.”
InfluentialSelf-citationPotential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake
Chung, N. S., & Wasan, K. M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.003 · Cited by 158
Deletion of Macrophage LDL Receptor–Related Protein Increases Atherogenesis in the Mouse
Overton, C. D., Yancey, P. G., Major, A. S., Linton, M. F., & Fazio, S. (2007) · Circulation Research · doi:10.1161/01.res.0000260204.40510.aa · Cited by 159
Conditional alleles in mice: Practical considerations for tissue‐specific knockouts
Kwan, K. M. (2002) · genesis · doi:10.1002/gene.10068 · Cited by 176
Morita, S. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00716 · Cited by 180
Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
Véniant, M. M., Zlot, C. H., Walzem, R. L., Pierotti, V., Driscoll, R. M., Dichek, D. A., Herz, J., & Young, S. G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4164 · Cited by 191
“The hyperlipidemia observed after Ad-RAP injection was much more severe than that in mice lacking LRP gene expression in the liver (13).”
InfluentialSelf-citationPostprandial lipoproteins and atherosclerosis
Kenneth, C.-W. Y. (2001) · Frontiers in bioscience · doi:10.2741/yu · Cited by 146
Neuronal LRP1 Regulates Glucose Metabolism and Insulin Signaling in the Brain
Liu, C., Hu, J., Tsai, C., Yue, M., Melrose, H. L., Kanekiyo, T., & Bu, G. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5180-14.2015 · Cited by 149
“Forebrain neuron-specific Lrp1-KO mice (nLrp1 / ) were generated by breeding the Lrp1 floxed mice (Rohlmann et al., 1998) with -calcium-calmodulindependent kinase II ( CaMKII)-driven Cre recombinase mice (The Jackson Laboratory).”
MethodMantuano, E., Brifault, C., Lam, M. S., Azmoon, P., Gilder, A. S., & Gonias, S. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515480113 · Cited by 149
“mLRP1 mice are homozygous for the floxed LRP1 gene but LysM-Cre-negative (21).”
BackgroundInfluentialVi, L., Baht, G. S., Soderblom, E. J., Whetstone, H., Wei, Q., Furman, B., Puviindran, V., Nadesan, P., Foster, M., Poon, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07666-0 · Cited by 140
Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation
Heeren, J., Grewal, T., Laatsch, A., Becker, N., Rinninger, F., Rye, K.-A., & Beisiegel, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409324200 · Cited by 139
Protection From Obesity in Mice Lacking the VLDL Receptor
Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E. H., Gijbels, M. J. J., van Dijk, K. W., Havekes, L. M., & Jong, M. C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095147 · Cited by 133
Low-Density Lipoprotein Receptor–Related Protein-1: Role in the Regulation of Vascular Integrity
Strickland, D. K., Au, D. T., Cunfer, P., & Muratoglu, S. C. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301924 · Cited by 140
“487 The low-density lipoprotein receptor–related protein-1 (LRP1) is a large endocytic receptor that was identified originally when Ashcom et al(1) and Moestrup et al(2) isolated and sequenced the liver receptor responsible for catabolism of α 2 macroglobulin:proteinase complexes(3,4) and Herz et al(5) cloned a large…”
BackgroundApolipoprotein E Recycling: Implications for Dyslipidemia and Atherosclerosis
Heeren, J., Beisiegel, U., & Grewal, T. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201282.64751.47 · Cited by 123
Heparan Sulphate Biosynthesis and Disease
Nadanaka, S., & Kitagawa, H. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn040 · Cited by 132
Engineering the mouse genome by site-specific recombination
METZGER, D., & Feil, R. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00012-9 · Cited by 128
Lipoprotein receptors – an evolutionarily ancient multifunctional receptor family
Dieckmann, M., Dietrich, M. F., & Herz, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.129 · Cited by 147
“…studies, mutations of LRP1B in urothelial malignancies (Langbein et al., 2002), esophageal squamous cell carcinomas (Sonoda et al., 2004), gliomas (Roversi et al., 2006), head and neck cancers (Nakagawa et al., 2006), cervical adenocarcinomas, B-cell lymphomas (Rahmatpanah et al., 2006), and…”
Self-citationBovenschen, N., Mertens, K., Hu, L., Havekes, L. M., & van Vlijmen, B. J. M. (2005) · Blood · doi:10.1182/blood-2004-11-4230 · Cited by 131
Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N., Kloosterhuis, N., Klug, H., Schepers, A., Willems van Dijk, K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312004 · Cited by 126
“As LDLR can compensate for the loss of LRP1, studying LRP1 functioning in the clearance of plasma ApoE and ApoB-containing particles in mice is only possible in a hepatic LDLR-deficient background (27).”
BackgroundInfluentialRegulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications
Xia, X.-D., Peng, Z.-S., Gu, H.-M., Wang, M., Wang, G.-Q., & Zhang, D.-W. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.764038 · Cited by 125
“Similarly, PCSK9 degrades LDLR but not LRP1 in mouse liver (21), but it can regulate visceral adipogenesis likely through promoting VLDLR degradation in mouse adipose tissues (22).”
BackgroundInfluentialMacrophage LRP1 contributes to the clearance of von Willebrand factor
Rastegarlari, G., Pegon, J. N., Casari, C., Odouard, S., Navarrete, A., Saint-Lu, N., van Vlijmen, B. J. M., Legendre, P., Christophe, O. D., Denis, C. V., et al. (2012) · Blood · doi:10.1182/blood-2011-08-373605 · Cited by 129
Bovenschen, N., Herz, J., Grimbergen, J. M., Lenting, P. J., Havekes, L. M., Mertens, K., & van Vlijmen, B. J. M. (2003) · Blood · doi:10.1182/blood-2002-07-2081 · Cited by 135
Self-citationDiverse role of LDL receptor-related protein in the clearance of proteases and in signaling
Strickland, D. K., & Ranganathan, S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00330.x · Cited by 126
Tomita, S., Sinal, C. J., Yim, S. H., & Gonzalez, F. J. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0533 · Cited by 147
Tamaki, C., Ohtsuki, S., Iwatsubo, T., Hashimoto, T., Yamada, K., Yabuki, C., & Terasaki, T. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0208-7 · Cited by 119
“loxP recombination system had no obvious negative effects on the apparent general health of animals, and also did not alter the plasma lipoprotein composition (40).”
BackgroundRegulation of Rac1 activation by the low density lipoprotein receptor–related protein
Ma, Z., Thomas, K. S., Webb, D. J., Moravec, R., Salicioni, A. M., Mars, W. M., & Gonias, S. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200207070 · Cited by 119
“Conditional LRP-1 gene targeting in the liver, using the Cre–loxP system, demonstrated a role for LRP-1 in the clearance of chylomicron remnants (Rohlmann et al., 1998); however, other LRP-1 functions were not addressed.”
Perlecan Heparan Sulfate Proteoglycan
Fuki, I. V., Iozzo, R. V., & Williams, K. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909173199 · Cited by 95
PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense
Jiang, H., Shi, H., Sun, M., Wang, Y., Meng, Q., Guo, P., Cao, Y., Chen, J., Gao, X., Li, E., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600474 · Cited by 117
“injection of poly(I:C) can elicit a robust, systemic type I IFN response in mice (29).”
BackgroundLRP1 is a neuronal receptor for α-synuclein uptake and spread
Chen, K., Martens, Y. A., Meneses, A., Ryu, D. H., Lu, W., Raulin, A. C., Li, F., Zhao, J., Chen, Y., Jin, Y., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00560-w · Cited by 115
“To investigate the role of Lrp1 in α-Syn spread in animals, we used the conditional neuronal Lrp1 knockout mice [38] by crossing Lrp1flox/flox mice with CaMKII-Cre mice to generate Lrp1-nKO (Lrp1flox/flox; Cre+/−) and WT littermate controls (Lrp1flox/flox; Cre−/−).”
MethodCholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein
Xie, C., Turley, S. D., Pentchev, P. G., & Dietschy, J. M. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.2.e336 · Cited by 116
“*Value in NPC2/2 mice was significantly different (P , 0.05) from that in control animals. by 10.220.33.2 on A ugust 15, 2017 http://ajpendo.physiology.org/ D ow nloaded from that the liver primarily clears chylomicron remnants utilizing both the LDLR and LRP (14, 30).”
BackgroundMethodInfluentialLipoprotein(a) catabolism: a case of multiple receptors
McCormick, S. P. A., & Schneider, W. J. (2019) · Pathology · doi:10.1016/j.pathol.2018.11.003 · Cited by 107
van de Sluis, B., Wijers, M., & Herz, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000411 · Cited by 111
“An initial study with conditional Lrp1 knockout mice showed that mice deficient for hepatocyte LRP1 are viable but do not have clear alterations in plasma lipid levels [3].”
BackgroundInfluentialSelf-citationLipodystrophy Syndrome in HIV Infection
Behrens, G. M. N., Stoll, M., & Schmidt, R. E. (2000) · Drug Safety · doi:10.2165/00002018-200023010-00004 · Cited by 107
“[126] Further arguments against the sequence homology hypothesis arose from a recent study[127] in which inactivation of the LPR gene in mice had no effect on the general health of the animals.”
BackgroundFuentealba, R. A., Liu, Q., Kanekiyo, T., Zhang, J., & Bu, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021030 · Cited by 97
Xie, C., Burns, D. K., Turley, S. D., & Dietschy, J. M. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1106 · Cited by 109
Uptake of lipoproteins for axonal growth of sympathetic neurons
Posse de Chaves, E. I., Vance, D. E., Campenot, R. B., Kiss, R. S., & Vance, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.26.19883 · Cited by 105
Xian, X., Ding, Y., Dieckmann, M., Zhou, L., Plattner, F., Liu, M., Parks, J. S., Hammer, R. E., Boucher, P., Tsai, S. X., et al. (2017) · eLife · doi:10.7554/elife.29292 · Cited by 107
“Together with LDLR, LRP1 regulates the clearance of circulating cholesterol-rich remnant proteins by hepatocytes (Rohlmann et al., 1998).”
BackgroundInfluentialSelf-citationEbara, T., Conde, K., Kako, Y., Liu, Y., Xu, Y., Ramakrishnan, R., Goldberg, I. J., & Shachter, N. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8283 · Cited by 86
“In otherwise normal mice, decreased LRP activity produces LDL-R upregulation and increased plasma apoB48 but no significant alterations in plasma TG and cholesterol have been reported (72).”
Background
Metadata
- Authors
- Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Max Delbrück Center (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-01
- Volume
- 101
- Issue
- 3
- Pages
- 689-695
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508614
- OpenAlex
- W2067089828
- Cited by
- 455
- References
- 33
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 9 · 2019: 9 · 2018: 18 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 8 · 2013: 17 · 2012: 19
- FWCI
- 33.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- LDL receptor-related protein, LRP, chylomicron remnants, cholesterol clearance, LDL receptor, conditional gene targeting, Cre-loxP recombination, liver, LDL receptor-deficient mice, lipoprotein metabolism
- MeSH terms
- Animals, Chylomicrons, Liver, Mice, Inbred C57BL, Mice, Transgenic, Receptors, Immunologic, Receptors, LDL, Recombination, Genetic, Viral Proteins, Mice, Knockout, Integrases, Low Density Lipoprotein Receptor-Related Protein-1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.